These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8357099)

  • 1. Increased plasma endothelin levels in Kawasaki disease: a possible marker for Kawasaki disease.
    Morise T; Takeuchi Y; Takeda R; Karayalcin U; Yachie A; Miyawaki T
    Angiology; 1993 Sep; 44(9):719-23. PubMed ID: 8357099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Change in plasma N-terminal pro-brain natriuretic peptide in children with Kawasaki disease and its value in clinical practice].
    Zhang QY; Du JB; Chen YH; Li WZ
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):886-90. PubMed ID: 17254452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of monocyte chemotactic protein-1 in peripheral blood mononuclear cells of children with Kawasaki disease and its relation to coronary artery impairment].
    Zhang J; Gui YH; Yang Y
    Zhonghua Er Ke Za Zhi; 2008 Feb; 46(2):132-5. PubMed ID: 19099689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in GlycA and lipoprotein particle parameters may help distinguish acute kawasaki disease from other febrile illnesses in children.
    Connelly MA; Shimizu C; Winegar DA; Shalaurova I; Pourfarzib R; Otvos JD; Kanegaye JT; Tremoulet AH; Burns JC
    BMC Pediatr; 2016 Sep; 16(1):151. PubMed ID: 27596163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating adiponectin levels in Kawasaki disease.
    Takeshita S; Takabayashi H; Yoshida N
    Acta Paediatr; 2006 Oct; 95(10):1312-4. PubMed ID: 16982510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum interleukin-6 in Kawasaki disease.
    Kim DS
    Yonsei Med J; 1992 Jun; 33(2):183-8. PubMed ID: 1413896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease.
    Ye Q; Shao WX; Shang SQ; Zhang T; Hu J; Zhang CC
    Arthritis Rheumatol; 2015 Jul; 67(7):1943-50. PubMed ID: 25778686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes of P-selectin and E-selectin in children with Kawasaki disease].
    Qiu Y; Wu J; Fang XY; Lin Z; Wu BY; Cai RY; Xu XY; Zheng H
    Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):688-92. PubMed ID: 15482673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel data-mining approach identifies biomarkers for diagnosis of Kawasaki disease.
    Tremoulet AH; Dutkowski J; Sato Y; Kanegaye JT; Ling XB; Burns JC
    Pediatr Res; 2015 Nov; 78(5):547-53. PubMed ID: 26237629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased serum interleukin-10 level in Kawasaki disease.
    Kim DS; Lee HK; Noh GW; Lee SI; Lee KY
    Yonsei Med J; 1996 Apr; 37(2):125-30. PubMed ID: 8711935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease.
    Kawamura T; Wago M; Kawaguchi H; Tahara M; Yuge M
    Pediatr Int; 2000 Jun; 42(3):241-8. PubMed ID: 10881579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL10/IP-10 is a biomarker and mediator for Kawasaki disease.
    Ko TM; Kuo HC; Chang JS; Chen SP; Liu YM; Chen HW; Tsai FJ; Lee YC; Chen CH; Wu JY; Chen YT
    Circ Res; 2015 Feb; 116(5):876-83. PubMed ID: 25605650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum YKL-40 levels in patients with Kawasaki disease.
    Kim KY; Ahn Y; Kim DY; Kim HS; Kim DS
    Biomarkers; 2017; 22(3-4):326-330. PubMed ID: 27881022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased plasma endothelin-1 concentration in Kawasaki disease.
    Ogawa S; Zhang J; Yuge K; Watanabe M; Fukazawa R; Kamisago M; Seki T; Hirayama T
    J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S364-6. PubMed ID: 7509988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on the relationship between mean platelet volume and platelet distribution width with coronary artery lesion in children with Kawasaki disease.
    Liu R; Gao F; Huo J; Yi Q
    Platelets; 2012; 23(1):11-6. PubMed ID: 21675937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased serum levels of vascular endothelial growth factor in Kawasaki disease.
    Maeno N; Takei S; Masuda K; Akaike H; Matsuo K; Kitajima I; Maruyama I; Miyata K
    Pediatr Res; 1998 Oct; 44(4):596-9. PubMed ID: 9773852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum thrombopoietin levels in Kawasaki disease.
    Miura N; Terai M; Meng YG; Sato T; Niimi H
    Br J Haematol; 1998 Feb; 100(2):387-8. PubMed ID: 9488632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophils and mononuclear cells express vascular endothelial growth factor in acute Kawasaki disease: its possible role in progression of coronary artery lesions.
    Hamamichi Y; Ichida F; Yu X; Hirono KI; Uese KI; Hashimoto I; Tsubata S; Yoshida T; Futatani T; Kanegane H; Miyawaki T
    Pediatr Res; 2001 Jan; 49(1):74-80. PubMed ID: 11134495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in and significance of platelet function and parameters in Kawasaki disease.
    Zheng X; Wu W; Zhang Y; Wu G
    Sci Rep; 2019 Nov; 9(1):17641. PubMed ID: 31776411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant laboratory marker of Kawasaki disease; NT-pro-BNP or hs-CRP?
    Cho SY; Kim Y; Cha SH; Suh JT; Han MY; Lee HJ
    Ann Clin Lab Sci; 2011; 41(4):360-3. PubMed ID: 22166506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.